ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
120.767,19
-1,73%
S&P 500
5.346,99
-0,11%
US Dollar vs BRL
5,3451
-0,02%
Bitcoin
69.387,00
0,08%
Brent Oil
79,395
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Ocuphire Pharma Inc (OCUP)

  7. Ocuphire Pharma Inc (OCUP) Notícias

OCUP

Ocuphire Pharma (OCUP)

Ocuphire Pharma Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:OCUP
DataHoraFonteTítuloCódigoCompanhia
24/05/202417:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
10/05/202417:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OCUPOcuphire Pharma Inc
10/05/202417:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCUPOcuphire Pharma Inc
08/03/202419:20Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:OCUPOcuphire Pharma Inc
16/02/202418:31Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:OCUPOcuphire Pharma Inc
14/02/202420:32Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:OCUPOcuphire Pharma Inc
24/01/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:OCUPOcuphire Pharma Inc
11/01/202418:16Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:OCUPOcuphire Pharma Inc
10/01/202419:00Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:OCUPOcuphire Pharma Inc
27/09/202309:00PR Newswire (US)Viatris and Ocuphire Pharma Announce FDA Approval of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% Eye Drops for the Treatment of Pharmacologically-Induced Mydriasis Produced by Adrenergic Agonists (e.g., Phenylephrine) or Parasympatholytic (e.g., TrNASDAQ:OCUPOcuphire Pharma Inc
14/08/202309:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:OCUPOcuphire Pharma Inc
14/06/202317:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OCUPOcuphire Pharma Inc
08/06/202319:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OCUPOcuphire Pharma Inc
15/05/202309:23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OCUPOcuphire Pharma Inc
01/05/202317:16Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:OCUPOcuphire Pharma Inc
01/05/202317:13Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OCUPOcuphire Pharma Inc
05/04/202318:05Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OCUPOcuphire Pharma Inc
30/03/202318:08Edgar (US Regulatory)Annual Report (10-k)NASDAQ:OCUPOcuphire Pharma Inc
14/02/202316:04Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:OCUPOcuphire Pharma Inc
06/12/202218:50TipRanksAnalysts Offer Insights on Healthcare Companies: Ocuphire Pharma (OCUP) and Irhythm Technologies (IRTC)NASDAQ:OCUPOcuphire Pharma Inc
23/11/202218:15TipRanksJonesTrading Remains a Buy on Ocuphire Pharma (OCUP)NASDAQ:OCUPOcuphire Pharma Inc
07/11/202208:15TipRanksH.C. Wainwright Keeps Their Buy Rating on Ocuphire Pharma (OCUP)NASDAQ:OCUPOcuphire Pharma Inc
17/10/202207:25TipRanksOcuphire Pharma (OCUP) Receives a Buy from H.C. WainwrightNASDAQ:OCUPOcuphire Pharma Inc
15/08/202207:20TipRanksWall Street Analysts Are Bullish on Top Healthcare PicksNASDAQ:OCUPOcuphire Pharma Inc
10/06/202217:17Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OCUPOcuphire Pharma Inc
22/05/202205:30TipRanksH.C. Wainwright Thinks Ocuphire Pharma’s Stock is Going to RecoverNASDAQ:OCUPOcuphire Pharma Inc
17/05/202217:38Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OCUPOcuphire Pharma Inc
25/03/202207:16TipRanksOcuphire Pharma (OCUP) Gets a Buy Rating from H.C. WainwrightNASDAQ:OCUPOcuphire Pharma Inc
14/02/202218:20Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OCUPOcuphire Pharma Inc
19/01/202216:45TipRanksOcuphire Pharma: A High-Risk, High-Reward StockNASDAQ:OCUPOcuphire Pharma Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:OCUP

Seu Histórico Recente

LSE
IN90
Euro.bk 27
LSE
CHIU
Ct Uk High U
COIN
APUUSD
Apu
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados